Skip to main content Skip to main navigation menu Skip to site footer

Fractional erbium: YSGG laser compared to the combination of fractional erbium: YSGG laser and topical autologous platelet-rich plasma for treatment of atrophic acne scars: a case report

  • Prasetyadi Mawardi ,
  • Adniana Nareswari ,

Abstract

Background: Acne scar is the most common complication in acne that occurs in about 49% of acne individuals. Fractional resurfacing lasers such as CO2 laser and erbium-doped yttrium aluminum garnet (Er: YAG) have been widely used for acne scar treatment and give satisfying results have complications such as pain, hyperpigmentation, infection, prolonged erythema, and scarring. Fractional erbium: yttrium scandium gallium garnet (Er: YSGG) laser solves previous laser techniques' disadvantages. It has an ideal wavelength of 2790 nm, which balances the epidermis layer's vaporization and thermal damage in the dermis's superficial layer. Platelet Rich Plasma (PRP) is an autologous concentration of human platelets in a small plasma volume that secreted various growth factors that can speed up the scar healing process.

Case report: A-24 years old male student came with a chief complaint of acne scars on his face four years before the examination. The patient's condition is classified as moderate-severe acne scarring based on Goodman and Baron's criteria (qualitative global acne scarring system). Acne scars treatment plan was single fractional erbium: YSGG laser for the left side of the face and combined fractional Er: YSGG laser with topical autologous PRP on the right side. This procedure was performed in 2 sessions with an interval of 4 weeks, the final evaluation at 12 weeks after the first procedure. Clinical improvement of acne scars was assessed using qualitative and quantitative scales based on Goodman and Baron's, patient and observer scar assessment scale (POSAS), quartile grading scale, and patient satisfaction level.

Conclusion: In the final evaluation, there was an improvement on the entire grading scale on the right side of the face (Er: YSGG laser + PRP) and the face's left side (Er: YSGG laser only). Post-treatment erythema was found on both sides of the patient's face but disappeared within three days on the face's right side and five days on the face's left side.

References

  1. Fife D. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. J Clin Aesthet Dermatol. 2011;4(8):50-7.
  2. Utley C & Gold M. Treating acne scars in 2020: Use of lasers. Dermatological Reviews. 2020;1-7.
  3. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19(4):303-8.
  4. Fabbrocini G, Annunziata MC, D’Arcov V, De Vita V, Lodi G, Mauriello MC, et al.Acne Scars: Pathogenesis, Classification and Treatment. Dermatology Study and Practice. 2010; 893080:1-13.
  5. Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg Med. 2006; 38(3):169-76.
  6. Jaffe BH, Walsh JT Jr. Water flux from partial-thickness skin wounds: comparative study of the effects of Er: YAG and Ho: YAG lasers.Lasers Surg Med. 1996;18(1):1-9.
  7. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62(4):489–96.
  8. Zhu JT, Xuan M, Zhang YN, Liu HW, Cai JH, Wu YH, et al. The efficacy of autologous platelet-rich plasma combined with erbium fractional laser treatment for facial acne scars or acne. Mol Med Rep. 2013;8(1):233-7.
  9. Gawdat HI, Hegazy RA, Fawzy MM, Fathy M. Autologous platelet rich plasma: topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars.Dermatol Surg. 2014;40(2):152-61.
  10. Goh C, Cheng C, Agak G, Zaenglein AL, Graber EM, Thiboutot DM, et al. Acne Vulgaris. Dalam: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editor. Fitzpatrick's dermatology in general medicine. 9th Edition. New York: McGraw Hill;
  11. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence.Adolesc Health Med Ther. 2016;7:13-25.
  12. Boen M, Jacob C. A Review and Update of Treatment Options Using the Acne Scar Classification System. Dermatol Surg. 2019;45(3), 411–22.
  13. Rhie JW, Shim JS, Choi WS. A Pilot Study of Skin Resurfacing Using the 2,790-nm Erbium:YSGG Laser System. Arch Plast Surg. 2015;42(1):52-8.
  14. Smith KC, Schachter GD. YSGG 2790-nm Superficial Ablative and Fractional Ablative Laser Treatment. Facial Plastic Surgery Clinics of North America. 2011;19(2):253–60.
  15. Lee JW, Kim BJ The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: a simultaneous split-face trial. Dermatol Surg. 2011; 37(7):931-8.
  16. Na JI, Choi JW, Choi HR, Jeong JB, Park KC, Youn SW, et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg. 2011; 37(4):463-8.
  17. Ross EV, Swann M, Soon S, Izadpanah A, Barnette D, Davenport S. Full-face treatments with the 2790-nm erbium:YSGG laser system. J Drugs Dermatol. 2009;8(3):248-52.
  18. Goodman GJ, Baron JA. Postacne scarring--a quantitative global scarring grading system. J Cosmet Dermatol. 2006; 5(1):48-52.
  19. Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg. 2007;33(3):295-9.
  20. Rhie JW, Shim JS, Choi WS. A Pilot Study of Skin Resurfacing Using the 2,790-nm Erbium:YSGG Laser System. Arch Plast Surg. 2015;42(1):52-8.
  21. Smith KC, Schachter GD. YSGG 2790-nm Superficial Ablative and Fractional Ablative Laser Treatment. Facial Plastic Surgery Clinics of North America. 2011;19(2):253–60.

How to Cite

Mawardi, P., & Nareswari, A. (2021). Fractional erbium: YSGG laser compared to the combination of fractional erbium: YSGG laser and topical autologous platelet-rich plasma for treatment of atrophic acne scars: a case report. Bali Medical Journal, 10(1), 58–62. https://doi.org/10.15562/bmj.v10i1.2240

HTML
2

Total
14

Share

Search Panel

Prasetyadi Mawardi
Google Scholar
Pubmed
BMJ Journal


Adniana Nareswari
Google Scholar
Pubmed
BMJ Journal